Patología Vascular y Trombosis
VYTRO
![Foto de Patología Vascular y Trombosis](/img/uploaded/5075ef166da9baf516d32c855e9e2d5b.jpg)
![Foto de Hospital Universitario de Canarias](/img/noimage_org.png)
Hospital Universitario de Canarias
San Cristóbal de La Laguna, EspañaPublications in collaboration with researchers from Hospital Universitario de Canarias (13)
2022
-
Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study
Clinical Kidney Journal, Vol. 15, Núm. 10, pp. 1856-1864
2020
-
Treatment with daratumumab in patients with relapsed/refractory AL amyloidosis: a multicentric retrospective study and review of the literature
Amyloid, Vol. 27, Núm. 3, pp. 163-167
2019
-
High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients
BMC neurology, Vol. 19, Núm. 1, pp. 167
-
Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients
Journal of Critical Care, Vol. 51, pp. 117-121
2015
2014
-
Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury
PLoS ONE, Vol. 9, Núm. 4
-
Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio
PLoS ONE, Vol. 9, Núm. 4
-
Sustained high plasma plasminogen activator inhibitor-1 levels are associated with severity and mortality in septic patients
Thrombosis Research, Vol. 134, Núm. 1, pp. 182-186
2013
2012
-
Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 32, Núm. 6, pp. 1477-1487
2011
-
Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis
Critical Care, Vol. 15, Núm. 2